Bain Capital Life Sciences Investors, LLC sold $56.1M of Heartflow (HTFL)

Executed Feb 4, disclosed Feb 6, 2 days later.

Value, as filed

$56.1M

2,000,000 sh × $28.05

Executed

Feb 4

the trade date, as filed

Disclosed

Feb 6

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

BL Bain Capital Life Sciences Investors, LLC 10% owner profile →

Bain Capital Life Sciences Investors, LLC (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (1 purchase, 1 sale), most often in Heartflow, Inc. (HTFL). Across 1 priced purchase filing, the average 21-session return was -26.2% from execution and -26.2% from disclosure (delay-adjusted; derived). The largest single filing was $56.1M of HTFL (2,000,000 sh × $28.05, as filed), executed Feb 4.

The name

HTFL

Heartflow, Inc. HTFL · Healthcare · 29 filings in 24 months ticker →

Healthcare · HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the Uni…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→